Analysts expect Viking Therapeutics, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 37.14 M | 42.25 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 34.93 M | 39.23 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 36.03 M | 40.74 M |
Analysts expect Viking Therapeutics, Inc. to report earnings per share of -1.03 for Q3 26, against a range of -1.12 to -0.94. The most recent reported quarter, Q2 26, came in at -1.10, a 15.4% beat against the -1.30 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.22 | -0.32 | -0.41 | -0.58 | -0.81 | -1.38 | -1.37 | -1.10 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.23 | -0.29 | -0.33 | -0.44 | -0.64 | -0.79 | -0.97 | -1.25 | -0.94 | -0.98 | -0.92 | -0.87 | -1.01 | -1.16 | -0.88 | -0.64 | ||||||||||
| Low Estimate | -0.27 | -0.31 | -0.37 | -0.50 | -0.72 | -0.91 | -1.11 | -1.35 | -1.12 | -1.12 | -0.98 | -0.99 | -1.09 | -1.30 | -1.02 | -0.74 | ||||||||||
| Consensus Estimate | -0.25 | -0.30 | -0.35 | -0.47 | -0.68 | -0.85 | -1.04 | -1.30 | -1.03 | -1.05 | -0.95 | -0.93 | -1.05 | -1.23 | -0.95 | -0.69 |
Pull Wall Street consensus for Viking Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=VKTX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "VKTX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=VKTX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();